Kambiz Yazdi
Stock Analyst at BTIG
(4.53)
# 1,025
Out of 4,609 analysts
71
Total ratings
64.8%
Success rate
26.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kambiz Yazdi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SION Sionna Therapeutics | Reiterated: Buy | $58 | $49.01 | +18.34% | 8 | Aug 6, 2026 | |
| ZVRA Zevra Therapeutics | Maintained: Buy | $24 | $11.58 | +107.34% | 6 | Aug 5, 2026 | |
| KZIA Kazia Therapeutics | Maintained: Buy | $34 | $12.55 | +170.92% | 3 | Jul 30, 2026 | |
| ABSI Absci | Maintained: Buy | $13 | $8.28 | +57.00% | 4 | Jul 30, 2026 | |
| VTVT vTv Therapeutics | Maintained: Buy | $49 → $57 | $34.00 | +67.65% | 7 | Jul 16, 2026 | |
| RAPP Rapport Therapeutics | Maintained: Buy | $65 | $45.07 | +44.22% | 8 | Jul 15, 2026 | |
| PRAX Praxis Precision Medicines | Maintained: Buy | $810 | $371.18 | +118.22% | 15 | Jun 29, 2026 | |
| BME: PHM Pharma Mar, S.A. | Initiated Coverage: Buy | €121.00 | €77.70 | +55.73% | 1 | Apr 23, 2026 | |
| ARQT Arcutis Biotherapeutics | Maintained: Buy | $31 | $26.45 | +17.20% | 6 | Jan 15, 2026 | |
| LQDA Liquidia | Reiterated: Buy | $27 → $31 | $89.17 | n/a | 6 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $23 | $18.41 | n/a | 1 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $12.72 | n/a | 1 | Aug 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $1.17 | n/a | 1 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $14 | $0.401375 | n/a | 3 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $7 | $0.0025 | n/a | 1 | May 31, 2023 |
Sionna Therapeutics
Aug 6, 2026
Reiterated: Buy
Price Target: $58
Current: $49.01
Upside: +18.34%
Zevra Therapeutics
Aug 5, 2026
Maintained: Buy
Price Target: $24
Current: $11.58
Upside: +107.34%
Kazia Therapeutics
Jul 30, 2026
Maintained: Buy
Price Target: $34
Current: $12.55
Upside: +170.92%
Absci
Jul 30, 2026
Maintained: Buy
Price Target: $13
Current: $8.28
Upside: +57.00%
vTv Therapeutics
Jul 16, 2026
Maintained: Buy
Price Target: $49 → $57
Current: $34.00
Upside: +67.65%
Rapport Therapeutics
Jul 15, 2026
Maintained: Buy
Price Target: $65
Current: $45.07
Upside: +44.22%
Praxis Precision Medicines
Jun 29, 2026
Maintained: Buy
Price Target: $810
Current: $371.18
Upside: +118.22%
Pharma Mar, S.A.
Apr 23, 2026
Initiated Coverage: Buy
Price Target: €121.00
Current: €77.70
Upside: +55.73%
Arcutis Biotherapeutics
Jan 15, 2026
Maintained: Buy
Price Target: $31
Current: $26.45
Upside: +17.20%
Liquidia
May 28, 2025
Reiterated: Buy
Price Target: $27 → $31
Current: $89.17
Upside: n/a
Mar 25, 2025
Initiated Coverage: Buy
Price Target: $23
Current: $18.41
Upside: n/a
Aug 28, 2024
Maintained: Buy
Price Target: $15
Current: $12.72
Upside: n/a
Apr 11, 2024
Initiated Coverage: Buy
Price Target: $5
Current: $1.17
Upside: n/a
Mar 7, 2024
Maintained: Buy
Price Target: $15 → $14
Current: $0.401375
Upside: n/a
May 31, 2023
Upgraded: Buy
Price Target: $7
Current: $0.0025
Upside: n/a